Skip to main content

KalVista Pharmaceuticals, Inc.

KALVDelisted Jun 11, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001348911

KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.

13F holders, Q4 2025

Institutional positions in KalVista Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
162
+18 vs. Q3 2025
Shares held
67.0M
+8.37M (+14.3%) vs. Q3 2025
Total value
$1.08B
+$367.7M (+51.5%) vs. Q3 2025
New holders
37
54 more added
Sold out
19
49 more reduced

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 162 institutions
Q1 2021: 117 institutionsQ2 2021: 110 institutionsQ3 2021: 105 institutionsQ4 2021: 97 institutionsQ1 2022: 89 institutionsQ2 2022: 91 institutionsQ3 2022: 94 institutionsQ4 2022: 91 institutionsQ1 2023: 88 institutionsQ2 2023: 94 institutionsQ3 2023: 101 institutionsQ4 2023: 93 institutionsQ1 2024: 129 institutionsQ2 2024: 119 institutionsQ3 2024: 122 institutionsQ4 2024: 130 institutionsQ1 2025: 128 institutionsQ2 2025: 140 institutionsQ3 2025: 145 institutionsQ4 2025: 162 institutionsQ1 2026: 184 institutionsQ2 2026: 1 institution
Value heldQ4 2025: $1.08B
Q1 2021: $605.1MQ2 2021: $582.7MQ3 2021: $408.2MQ4 2021: $314.6MQ1 2022: $363.9MQ2 2022: $238.7MQ3 2022: $372.0MQ4 2022: $236.2MQ1 2023: $265.0MQ2 2023: $310.1MQ3 2023: $349.2MQ4 2023: $453.0MQ1 2024: $557.2MQ2 2024: $568.2MQ3 2024: $561.0MQ4 2024: $467.4MQ1 2025: $633.7MQ2 2025: $615.5MQ3 2025: $714.0MQ4 2025: $1.08BQ1 2026: $1.39BQ2 2026: $189
Institutions holding KALV and their total value by quarter
QuarterHoldersValue
Q2 20261$189
Q1 2026184$1.39B
Q4 2025162$1.08B
Q3 2025145$714.0M
Q2 2025140$615.5M
Q1 2025128$633.7M
Q4 2024130$467.4M
Q3 2024122$561.0M
Q2 2024119$568.2M
Q1 2024129$557.2M
Q4 202393$453.0M
Q3 2023101$349.2M
Q2 202394$310.1M
Q1 202388$265.0M
Q4 202291$236.2M
Q3 202294$372.0M
Q2 202291$238.7M
Q1 202289$363.9M
Q4 202197$314.6M
Q3 2021105$408.2M
Q2 2021110$582.7M
Q1 2021117$605.1M

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q3 2025.

Institutions holding KALV in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Quest Partners LLC52,190$842.9K0.05%+415+0.8%Added
Swiss National Bank54,900$886.6K0.00%+6,400+13.2%Added
Wells Fargo & Company56,014$904.6K0.00%+18,770+50.4%Added
Russell Investments Group, Ltd.56,249$908.4K0.00%+53+0.1%Added
Birchview Capital, LP57,000$920.5K0.54%−10,000−14.9%Reduced
Brevan Howard Capital Management LP59,147$955.2K0.02%+3,269+5.9%Added
Rafferty Asset Management, LLC65,593$1.06M0.00%+7,803+13.5%Added
Susquehanna International Group, LLP71,895$1.16M0.00%−321,444−81.7%Reduced
Invesco Ltd.77,864$1.26M0.00%+14,621+23.1%Added
Jump Financial, LLC90,742$1.47M0.02%+90,742New
Nuveen, LLC107,129$1.73M0.00%+27,371+34.3%Added
Panagora Asset Management Inc109,391$1.77M0.01%−87,944−44.6%Reduced
FMR LLC111,807$1.81M0.00%+19,439+21.0%Added
Caption Management, LLC117,907$1.90M0.08%−23,515−16.6%Reduced
Wellington Management Group LLP122,379$1.98M0.00%−3,673−2.9%Reduced
Raymond James Financial Inc129,517$2.09M0.00%−19,789−13.3%Reduced
NEXTBio Capital Management LP131,796$2.13M1.25%+131,796New
Nan Fung Trinity (HK) Ltd154,522$2.50M0.20%00.0%Unchanged
Renaissance Technologies LLC165,151$2.67M0.00%+165,151New
F/M Investments LLC236,690$3.82M0.15%+37,486+18.8%Added
Atom Investors LP276,113$4.46M0.35%+276,113New
HRT Financial LP287,052$4.63M0.01%+287,052New
Schonfeld Strategic Advisors LLC305,880$4.94M0.02%−140,492−31.5%Reduced
Charles Schwab Investment Management Inc324,369$5.24M0.00%+2,402+0.7%Added
Hennion & Walsh Asset Management, Inc.341,819$5.52M0.19%+165,236+93.6%Added
Skandinaviska Enskilda Banken AB (publ)351,305$5.68M0.02%+150,314+74.8%Added
Northern Trust Corp351,973$5.68M0.00%+1,250+0.4%Added
DAFNA Capital Management LLC356,802$5.76M1.34%−65,929−15.6%Reduced
Blue Owl Capital Holdings LP360,000$5.81M1.79%+235,000+188.0%Added
UBS Group AG371,993$6.01M0.00%−82,155−18.1%Reduced
OrbiMed Advisors LLC382,400$6.18M0.13%+382,400New
Spruce Street Capital LP387,968$6.27M2.07%+387,968New
Bank of America Corp389,813$6.30M0.00%+25,404+7.0%Added
Freestone Grove Partners LP633,019$10.2M0.07%−71,429−10.1%Reduced
Great Point Partners LLC685,632$11.1M3.59%+685,632New
Bank of New York Mellon Corp695,175$11.2M0.00%+98,701+16.5%Added
Squadron Capital Management LLC700,000$11.3M5.04%+700,000New
Morgan Stanley700,228$11.3M0.00%+135,372+24.0%Added
Barclays PLC700,573$11.3M0.00%+122,669+21.2%Added
Armistice Capital, LLC800,000$12.9M0.32%+800,000New
Elmind Capital, LP801,300$12.9M3.82%+801,300New
Goldman Sachs Group Inc835,304$13.5M0.00%−964,877−53.6%Reduced
Emerald Mutual Fund Advisers Trust855,461$13.8M0.67%−62,514−6.8%Reduced
Geode Capital Management, LLC944,077$15.3M0.00%+15,406+1.7%Added
Schroder Investment Management Group1,171,755$18.9M0.01%+13,298+1.1%Added
Octagon Capital Advisors LP1,273,333$20.6M2.57%00.0%Unchanged
Emerald Advisers, LLC1,340,495$21.6M0.67%−10,759−0.8%Reduced
Parkman Healthcare Partners LLC1,768,508$28.6M2.72%+33,505+1.9%Added
Kynam Capital Management, LP1,810,954$29.2M1.90%+1,204,783+198.8%Added
Vestal Point Capital, LP1,890,000$30.5M1.12%+1,140,000+152.0%Added
State Street Corp1,911,691$30.9M0.00%+336,195+21.3%Added
Woodline Partners LP1,921,092$31.0M0.12%+4280.0%Added
Point72 Asset Management, L.P.2,283,766$36.9M0.06%+2,283,766New
Silverarc Capital Management, LLC2,427,118$39.2M5.67%+1,063,740+78.0%Added
Vanguard Group Inc2,509,020$40.5M0.00%+7,901+0.3%Added
Capital World Investors2,808,583$45.4M0.01%−369,004−11.6%Reduced
Millennium Management LLC2,896,666$46.8M0.03%+800,443+38.2%Added
BlackRock, Inc.3,754,148$60.6M0.00%+628,031+20.1%Added
Tang Capital Management LLC4,573,530$73.9M3.65%−468,268−9.3%Reduced
Suvretta Capital Management, LLC4,768,712$77.0M1.92%00.0%Unchanged
Frazier Life Sciences Management, L.P.5,039,867$81.4M2.19%00.0%Unchanged
VR Adviser, LLC6,728,985$108.7M5.37%00.0%Unchanged
Sio Capital Management, LLC0$00.00%−683,819−100.0%Sold out
Marshall Wace, LLP0$00.00%−370,773−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−325,435−100.0%Sold out
Jefferies Financial Group Inc.0$00.00%−286,875−100.0%Sold out
SummitTX Capital, L.P.0$00.00%−143,561−100.0%Sold out
Susquehanna Portfolio Strategies, LLC0$00.00%−128,011−100.0%Sold out
Boothbay Fund Management, LLC0$00.00%−107,283−100.0%Sold out
StemPoint Capital LP0$00.00%−56,770−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−45,444−100.0%Sold out
Artia Global Partners LP0$00.00%−41,555−100.0%Sold out
Capstone Investment Advisors, LLC0$00.00%−21,421−100.0%Sold out
D. E. Shaw & Co., Inc.0$00.00%−21,100−100.0%Sold out
Axq Capital, LP0$00.00%−17,213−100.0%Sold out
DRW Securities, LLC0$00.00%−16,775−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−10,686−100.0%Sold out
Wolverine Asset Management LLC0$00.00%−4,662−100.0%Sold out
CIBC Private Wealth Group, LLC0$00.00%−160−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−23−100.0%Sold out
IFP Advisors, Inc0$00.00%−5−100.0%Sold out
HAP Trading, LLC––––Not filed